128 related articles for article (PubMed ID: 18559600)
1. Heterogeneous ribonucleoprotein k and thymidine phosphorylase are independent prognostic and therapeutic markers for nasopharyngeal carcinoma.
Chen LC; Hsueh C; Tsang NM; Liang Y; Chang KP; Hao SP; Yu JS; Chang YS
Clin Cancer Res; 2008 Jun; 14(12):3807-13. PubMed ID: 18559600
[TBL] [Abstract][Full Text] [Related]
2. Heterogeneous ribonucleoprotein K and thymidine phosphorylase are independent prognostic and therapeutic markers for oral squamous cell carcinoma.
Wu CS; Chang KP; Chen LC; Chen CC; Liang Y; Hseuh C; Chang YS
Oral Oncol; 2012 Jun; 48(6):516-22. PubMed ID: 22321252
[TBL] [Abstract][Full Text] [Related]
3. Thymidine phosphorylase mRNA stability and protein levels are increased through ERK-mediated cytoplasmic accumulation of hnRNP K in nasopharyngeal carcinoma cells.
Chen LC; Liu HP; Li HP; Hsueh C; Yu JS; Liang CL; Chang YS
Oncogene; 2009 Apr; 28(17):1904-15. PubMed ID: 19330019
[TBL] [Abstract][Full Text] [Related]
4. The antiapoptotic protein, FLIP, is regulated by heterogeneous nuclear ribonucleoprotein K and correlates with poor overall survival of nasopharyngeal carcinoma patients.
Chen LC; Chung IC; Hsueh C; Tsang NM; Chi LM; Liang Y; Chen CC; Wang LJ; Chang YS
Cell Death Differ; 2010 Sep; 17(9):1463-73. PubMed ID: 20224598
[TBL] [Abstract][Full Text] [Related]
5. Epstein-Barr virus latent membrane protein 1 induces the chemotherapeutic target, thymidine phosphorylase, via NF-kappaB and p38 MAPK pathways.
Chen CC; Chen LC; Liang Y; Tsang NM; Chang YS
Cell Signal; 2010 Jul; 22(7):1132-42. PubMed ID: 20214978
[TBL] [Abstract][Full Text] [Related]
6. Matrix metalloproteinase 12 is induced by heterogeneous nuclear ribonucleoprotein K and promotes migration and invasion in nasopharyngeal carcinoma.
Chung IC; Chen LC; Chung AK; Chao M; Huang HY; Hsueh C; Tsang NM; Chang KP; Liang Y; Li HP; Chang YS
BMC Cancer; 2014 May; 14():348. PubMed ID: 24885469
[TBL] [Abstract][Full Text] [Related]
7. Thymidine phosphorylase expression correlates with malignant potential and anti-tumor effect of doxifluridine on gastric cancer: multivariate analysis for adjuvant chemotherapy doxifluridine vs. 5-fluorouracil.
Takiguchi N; Ishii R; Koda K; Oda K; Miyazaki M
Oncol Rep; 2003; 10(5):1105-11. PubMed ID: 12883665
[TBL] [Abstract][Full Text] [Related]
8. Prostate cancer: prognostic significance of the association of heterogeneous nuclear ribonucleoprotein K and androgen receptor expression.
Barboro P; Salvi S; Rubagotti A; Boccardo S; Spina B; Truini M; Carmignani G; Introini C; Ferrari N; Boccardo F; Balbi C
Int J Oncol; 2014 May; 44(5):1589-98. PubMed ID: 24626777
[TBL] [Abstract][Full Text] [Related]
9. Predictive role of thymidylate synthase, dihydropyrimidine dehydrogenase and thymidine phosphorylase expression in colorectal cancer patients receiving adjuvant 5-fluorouracil.
Ciaparrone M; Quirino M; Schinzari G; Zannoni G; Corsi DC; Vecchio FM; Cassano A; La Torre G; Barone C
Oncology; 2006; 70(5):366-77. PubMed ID: 17179731
[TBL] [Abstract][Full Text] [Related]
10. Elevated expressions of survivin and VEGF protein are strong independent predictors of survival in advanced nasopharyngeal carcinoma.
Li YH; Hu CF; Shao Q; Huang MY; Hou JH; Xie D; Zeng YX; Shao JY
J Transl Med; 2008 Jan; 6():1. PubMed ID: 18171482
[TBL] [Abstract][Full Text] [Related]
11. High expression of nuclear Snail, but not cytoplasmic staining, predicts poor survival in nasopharyngeal carcinoma.
Luo WR; Li SY; Cai LM; Yao KT
Ann Surg Oncol; 2012 Sep; 19(9):2971-9. PubMed ID: 22476819
[TBL] [Abstract][Full Text] [Related]
12. Centromere protein H is a novel prognostic marker for nasopharyngeal carcinoma progression and overall patient survival.
Liao WT; Song LB; Zhang HZ; Zhang X; Zhang L; Liu WL; Feng Y; Guo BH; Mai HQ; Cao SM; Li MZ; Qin HD; Zeng YX; Zeng MS
Clin Cancer Res; 2007 Jan; 13(2 Pt 1):508-14. PubMed ID: 17255272
[TBL] [Abstract][Full Text] [Related]
13. Prognostic and predictive value of thymidine phosphorylase activity in early-stage breast cancer patients.
Tominaga T; Toi M; Ohashi Y; Abe O;
Clin Breast Cancer; 2002 Apr; 3(1):55-64. PubMed ID: 12020396
[TBL] [Abstract][Full Text] [Related]
14. Cytoplasmic Accumulation of Heterogeneous Nuclear Ribonucleoprotein K Strongly Promotes Tumor Invasion in Renal Cell Carcinoma Cells.
Otoshi T; Tanaka T; Morimoto K; Nakatani T
PLoS One; 2015; 10(12):e0145769. PubMed ID: 26713736
[TBL] [Abstract][Full Text] [Related]
15. The ratio of thymidine phosphorylase to dihydropyrimidine dehydrogenase in tumour tissues of patients with metastatic gastric cancer is predictive of the clinical response to 5'-deoxy-5-fluorouridine.
Nishina T; Hyodo I; Miyaike J; Inaba T; Suzuki S; Shiratori Y
Eur J Cancer; 2004 Jul; 40(10):1566-71. PubMed ID: 15196541
[TBL] [Abstract][Full Text] [Related]
16. Thymidine phosphorylase expression is useful in selecting adjuvant chemotherapy for stage III gastric cancer.
Ishii R; Takiguchi N; Oda K; Koda K; Miyazaki M
Int J Oncol; 2001 Oct; 19(4):717-22. PubMed ID: 11562746
[TBL] [Abstract][Full Text] [Related]
17. Effect of S-phase kinase-associated protein 2 expression on distant metastasis and survival in nasopharyngeal carcinoma patients.
Fang FM; Chien CY; Li CF; Shiu WY; Chen CH; Huang HY
Int J Radiat Oncol Biol Phys; 2009 Jan; 73(1):202-7. PubMed ID: 18538504
[TBL] [Abstract][Full Text] [Related]
18. Expression level of NUAK1 in human nasopharyngeal carcinoma and its prognostic significance.
Liu J; Tang G; Huang H; Li H; Zhang P; Xu L
Eur Arch Otorhinolaryngol; 2018 Oct; 275(10):2563-2573. PubMed ID: 30121842
[TBL] [Abstract][Full Text] [Related]
19. Loss of cytoplasmic KLF4 expression is correlated with the progression and poor prognosis of nasopharyngeal carcinoma.
Liu Z; Yang H; Luo W; Jiang Q; Mai C; Chen Y; Zhen Y; Yu X; Long X; Fang W
Histopathology; 2013 Sep; 63(3):362-70. PubMed ID: 23758499
[TBL] [Abstract][Full Text] [Related]
20. Role of thymidine phosphorylase and dihydropyrimidine dehydrogenase in tumour progression and sensitivity to doxifluridine in gastric cancer patients.
Terashima M; Fujiwara H; Takagane A; Abe K; Araya M; Irinoda T; Yonezawa H; Nakaya T; Oyama K; Takahashi M; Saito K
Eur J Cancer; 2002 Dec; 38(18):2375-81. PubMed ID: 12460781
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
